An Open-label, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function.
Latest Information Update: 13 Jan 2012
At a glance
- Drugs Patupilone (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2009 Lead trial investigators identified as reported by ClinicalTrials.gov.